Lista de obras -

A Pilot Study and Ecological Model of Smoking Cues to Inform Mobile Health Strategies for Quitting Among Low-Income Smokers

artículo científico publicado en 2020

A Test in Context: Hemoglobin A1c and Cardiovascular Disease

artículo científico publicado en 2016

Accuracy of estimating resting oxygen uptake and implications for hemodynamic assessment.

artículo científico publicado en 2011

Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution ⬇️

artículo científico publicado el 9 de mayo de 2011

Advancing evidence-based digital health through an innovative research environment: an academic-industry collaboration case report

scientific article published on 20 September 2019

Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

artículo científico publicado en 2014

Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment

artículo científico publicado en 2011

Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study

artículo científico publicado en 2014

Cardiac Troponins and the Future of Precision Medicine

artículo científico publicado en 2016

Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs

artículo científico publicado en 2009

Clinical Relevance of the 99th Percentile Upper Reference Limit for High-Sensitivity Cardiac Troponin Assays

scientific article published on 01 March 2020

Diabetes and heart failure in patients with coronary disease: separating markers from mediators

artículo científico publicado en 2010

Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction

artículo científico publicado en 2012

Diabetes mellitus in patients with myocardial infarction complicated by heart failure: a ‘low ejection fraction’ equivalent? ⬇️

artículo científico publicado el 1 de noviembre de 2010

Discordant effects of rosiglitazone on novel inflammatory biomarkers ⬇️

artículo científico publicado el 16 de febrero de 2013

Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment

artículo científico publicado en 2012

Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus

artículo científico publicado en 2015

Elements of Social Convoy Theory in Mobile Health for Palliative Care: Scoping Review

scientific article published on 06 January 2020

Glycated hemoglobin in 14,850 adolescent blood donors: a pilot screening program

artículo científico publicado en 2014

High prevalence of elevated haemoglobin A1C among adolescent blood donors: Results from a voluntary screening programme including 31,546 adolescents

artículo científico publicado en 2015

Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study

artículo científico publicado en 2014

Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors

scientific article published on 01 July 2019

Inaccuracy of estimated resting oxygen uptake in the clinical setting

artículo científico publicado en 2013

Insulin resistance and risk for incident heart failure

artículo científico publicado en 2013

Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?

artículo científico publicado en 2014

Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges

artículo científico

Racial Differences in Cardiovascular Biomarkers in the General Population

artículo científico publicado en 2019

Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis

artículo científico publicado en 2008

Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments ⬇️

artículo científico publicado el 6 de abril de 2011

Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study

artículo científico publicado en 2013

The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context

artículo científico publicado en 2009

The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial ⬇️

artículo científico publicado el 8 de noviembre de 2011

Type of β-blocker use among patients with versus without diabetes after myocardial infarction

artículo científico publicado en 2014

Lista de obras de

A Pilot Study and Ecological Model of Smoking Cues to Inform Mobile Health Strategies for Quitting Among Low-Income Smokers

A Test in Context: Hemoglobin A1c and Cardiovascular Disease

Accuracy of estimating resting oxygen uptake and implications for hemodynamic assessment.

Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution ⬇️

Advancing evidence-based digital health through an innovative research environment: an academic-industry collaboration case report

Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment

Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study

Cardiac Troponins and the Future of Precision Medicine

Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs

Clinical Relevance of the 99th Percentile Upper Reference Limit for High-Sensitivity Cardiac Troponin Assays

Diabetes and heart failure in patients with coronary disease: separating markers from mediators

Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction

Diabetes mellitus in patients with myocardial infarction complicated by heart failure: a ‘low ejection fraction’ equivalent? ⬇️

Discordant effects of rosiglitazone on novel inflammatory biomarkers ⬇️

Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment

Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus

Elements of Social Convoy Theory in Mobile Health for Palliative Care: Scoping Review

Glycated hemoglobin in 14,850 adolescent blood donors: a pilot screening program

High prevalence of elevated haemoglobin A1C among adolescent blood donors: Results from a voluntary screening programme including 31,546 adolescents

Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study

Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors

Inaccuracy of estimated resting oxygen uptake in the clinical setting

Insulin resistance and risk for incident heart failure

Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?

Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges

Racial Differences in Cardiovascular Biomarkers in the General Population

Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis

Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments ⬇️

Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study

The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context

The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial ⬇️

Type of β-blocker use among patients with versus without diabetes after myocardial infarction